Global Journal of Life Sciences and Biological Research
Open Access

Stem Cell Banking and Tissue Engineering Innovations in Stem Cell Technology

Deenah Osman^{* *}Correspondence: Deenah Osman, Department of Biotechnology, Sangmyung University, Seoul, Korea, Email:

Author info »

About the Study

Stem cell technology represents a frontier in biomedical science, offering remarkable potential for revolutionizing healthcare and advancing our understanding of human biology. Stem cells, characterized by their unique ability to self-renew and differentiate into various specialized cell types, hold potential for regenerative medicine, disease modelling, and drug discovery. This transformative field surrounds both embryonic and adult stem cells, each with distinct advantages and applications. Embryonic stem cells, derived from early-stage embryos, possess pluripotent capabilities, making them versatile for generating any cell type in the body. In contrast, adult stem cells, found in tissues throughout the body, contribute to tissue maintenance and repair. Recent advancements in induced Pluripotent Stem Cells (iPSCs) further underscore the potential to reprogram adult cells into a pluripotent state, bypassing ethical concerns associated with embryonic sources. stem cell technology continues to redefine therapeutic possibilities, offering hope for personalized treatments and deep insights into human development and disease mechanisms.

Emerging trends in induced pluripotent stem cells

Induced Pluripotent Stem Cells (iPSCs) are reshaping biomedical research and therapeutic applications. Initially derived by reprogramming adult cells into a pluripotent state akin to embryonic stem cells, iPSC technology has evolved rapidly [1]. Recent advancements focus on enhancing iPSC generation efficiency, improving differentiation protocols into specific cell types relevant for disease modeling and regenerative medicine, and standardizing iPSC-derived cell therapies for clinical use. Novel techniques such as CRISPR-Cas9 gene editing are enabling precise genetic modifications in iPSCs, facilitating disease modeling with patient-specific mutations and enhancing the safety and efficacy of cell-based therapies [2,3]. Moreover, collaborative efforts among academia, industry, and regulatory bodies are streamlining iPSC-based research and translation to clinical applications. As iPSC technology continues to mature, its potential to revolutionize personalized medicine, drug discovery, and regenerative therapies grows, potential transformative impacts on healthcare by offering customized treatments and insights into complex diseases [4].

Stem cells and tissue engineering innovations

Stem cells are at the forefront of revolutionary advancements in tissue engineering, offering unprecedented opportunities to regenerate and replace damaged tissues. Through innovative approaches, stem cells are being utilized to create bioengineered tissues and organs that mimic the body's natural structures and functions [5,6]. Techniques such as scaffold-based tissue engineering and organoid culture systems enable the cultivation of complex tissues from stem cells, encourage developments in regenerative medicine and disease modeling. Furthermore, the integration of biomaterials and biocompatible scaffolds enhances the viability and functionality of engineered tissues, paving the way for personalized implants and therapeutic solutions [7]. These innovations not only hold promise for treating injuries and diseases that conventional therapies struggle to address but also present new methods for studying developmental biology and advancing our understanding of tissue regeneration processes. As research progresses, the convergence of stem cells and tissue engineering continues to redefine possibilities in healthcare, aiming towards more effective and sustainable treatments [8].

Potential for stem cell banking

Stem cell banking, also known as cryopreservation of stem cells, is increasingly recognized for its potential in personalized medicine and regenerative therapies. It involves the collection and storage of stem cells from various sources, including umbilical cord blood, bone marrow, and adipose tissue, for future therapeutic use. These stored stem cells can be utilized to treat a wide range of conditions, from blood disorders to autoimmune diseases and certain cancers [9].

The future prospects of stem cell banking are potential, driven by advancements in preservation techniques and expanding applications in clinical practice. As technologies improve, there is growing interest in establishing public and private stem cell banks worldwide. These repositories not only provide a valuable resource for immediate family members but also support research efforts into novel treatments and personalized therapies [10]. Moreover, the integration of stem cell banking with genetic profiling and medical data promises to enhance precision medicine approaches, potentially revolutionizing healthcare by offering customized regenerative solutions to patients in need.

References

1. Agudo J, Park ES, Rose SA, Alibo E, Sweeney R, Dhainaut M, et al. Quiescent tissue stem cells evade immune surveillance. Immunity. 2018; 48(2):271-285.

   [Crossref] [Google Scholar] [PubMed]

2. Ali N, Zirak B, Rodriguez RS, Pauli ML, Truong HA, Lai K, et al. Regulatory T cells in skin facilitate epithelial stem cell differentiation. Cell. 2017;169(6):1119-1129.

   [Crossref] [Google Scholar] [PubMed]

3. Andersen J, Urbán N, Achimastou A, Ito A, Simic M, Ullom K, et al. A transcriptional mechanism integrating inputs from extracellular signals to activate hippocampal stem cells. Neuron. 2014;83(5):1085-1097.

   [Crossref] [Google Scholar] [PubMed]

4. Andreu Z, Khan MA, González-Gómez P, Negueruela S, Hortigüela R, San Emeterio J, et al. The cyclin-dependent kinase inhibitor p27kip1 regulates radial stem cell quiescence and neurogenesis in the adult hippocampus. Stem Cells. 2015;33(1):219-229.

   [Crossref] [Google Scholar] [PubMed]

5. Barker N, Van Es JH, Kuipers J, Kujala P, Van Den Born M, Cozijnsen M, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449(7165):1003-1007.

   [Crossref] [Google Scholar] [PubMed]

6. Barriga FM, Montagni E, Mana M, Mendez-Lago M, Hernando-Momblona X, Sevillano M, et al. Mex3a marks a slowly dividing subpopulation of Lgr5+ intestinal stem cells. Cell stem cell. 2017;20(6):801-816.

   [Crossref] [Google Scholar] [PubMed]

7. Baser A, Skabkin M, Martin-Villalba A. Neural stem cell activation and the role of protein synthesis. Brain Plast. 2017;3(1):27-41.

   [Crossref] [Google Scholar] [PubMed]

8. Baumgartner C, Toifl S, Farlik M, Halbritter F, Scheicher R, Fischer I, et al. An ERK-dependent feedback mechanism prevents hematopoietic stem cell exhaustion. Cell stem cell.2018;22(6):879-892.

   [Crossref] [Google Scholar] [PubMed]

9. Bernitz JM, Kim HS, MacArthur B, Sieburg H, Moore K. Hematopoietic stem cells count and remember self-renewal divisions. Cell. 2016;167(5):1296-1309.

   [Crossref] [Google Scholar] [PubMed]

10. Bernstein BE, Humphrey EL, Erlich RL, Schneider R, Bouman P, Liu JS, et al. Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci. 2002 Jun 25;99(13):8695-700.

    [Crossref] [Google Scholar] [PubMed]